Trade INCR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Intercure Ltd. (INCR) is trading at US$5.25, down 1.22% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$10.09M. Over the past 52 weeks, INCR has traded between US$0.68 and US$6.10. On Syfe you can trade INCR with $0 commission and add it to your watchlist.
| Previous close | US$5.31 |
|---|---|
| Market cap | US$10.09M |
| 52-week range | US$0.68 – US$6.10 |
| Volume | 491 |
| Exchange | US |
Add to Watchlist
Set Price Alert
Intercure Ltd.
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. It operates through the Investments in Biomed Portfolio Companies in the Biomed Sector and Investments in the Medical Cannabis Sector segments. The company was founded by Benjamin Gavish and Erez Gavish on November 20, 1994 and is headquartered in Herzliya, Israel.
Year: 2019
InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition
Jun 15, 2:00 PM · MT Newswires
Intercure Ltd. (INCR) stock is trading at US$5.25, -1.22% from the previous close of US$5.31.
The market cap for Intercure Ltd. (INCR) stock is approximately US$10.09M.
The 52-week high for Intercure Ltd. (INCR) stock is US$6.10.
The 52-week low for Intercure Ltd. (INCR) stock is US$0.68.
Intercure Ltd. (INCR) does not currently pay a dividend.
Stay on top of INCR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
